These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 9218619)

  • 21. Role of complement in a murine model of peanut-induced anaphylaxis.
    Kodama T; Sekine H; Takahashi M; Iwaki D; Machida T; Kanno K; Ishida Y; Endo Y; Fujita T
    Immunobiology; 2013 Jun; 218(6):844-50. PubMed ID: 23182714
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of C1 inhibitor on intestinal ischemia and reperfusion injury.
    Lu F; Chauhan AK; Fernandes SM; Walsh MT; Wagner DD; Davis AE
    Am J Physiol Gastrointest Liver Physiol; 2008 Nov; 295(5):G1042-9. PubMed ID: 18787060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of complement receptors 1 and 2 (CD35 and CD21), C3, C4, and C5 in survival by mice of Staphylococcus aureus bacteremia.
    Cunnion KM; Benjamin DK; Hester CG; Frank MM
    J Lab Clin Med; 2004 Jun; 143(6):358-65. PubMed ID: 15192652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impaired mast cell-dependent natural immunity in complement C3-deficient mice.
    Prodeus AP; Zhou X; Maurer M; Galli SJ; Carroll MC
    Nature; 1997 Nov; 390(6656):172-5. PubMed ID: 9367154
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An anti-endotoxin peptide that generates from the amino-terminal domain of complement regulatory protein C1 inhibitor.
    Zhang H; Li J; Barrington RA; Liang G; Qin G; Liu DX
    Biochem Biophys Res Commun; 2007 Jul; 359(2):285-91. PubMed ID: 17543887
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Guinea pigs deficient in C2, C4, C3 or the C3a receptor.
    Bitter-Suermann D; Burger R
    Prog Allergy; 1986; 39():134-58. PubMed ID: 3550815
    [No Abstract]   [Full Text] [Related]  

  • 27. Serum concentrations of immunoglobulins and complement components in patients with recurrence after resection of gastric carcinoma.
    Janssen CW; Tønder O; Matre R
    Cancer Detect Prev; 1987; 10(3-4):303-9. PubMed ID: 3568028
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of various forms of the C1 esterase inhibitor (C1-INH) and DAF on complement mediated xenogeneic cell lysis.
    Fukuta D; Miyagawa S; Yamada M; Matsunami K; Kurihara T; Shirasu A; Hattori H; Shirakura R
    Xenotransplantation; 2003 Mar; 10(2):132-41. PubMed ID: 12588646
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endotoxin-induced pulmonary dysfunction is prevented by C1-esterase inhibitor.
    Guerrero R; Velasco F; Rodriguez M; Lopez A; Rojas R; Alvarez MA; Villalba R; Rubio V; Torres A; del Castillo D
    J Clin Invest; 1993 Jun; 91(6):2754-60. PubMed ID: 8514883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The third component of complement protects against Escherichia coli endotoxin-induced shock and multiple organ failure.
    Quezado ZM; Hoffman WD; Winkelstein JA; Yatsiv I; Koev CA; Cork LC; Elin RJ; Eichacker PQ; Natanson C
    J Exp Med; 1994 Feb; 179(2):569-78. PubMed ID: 8294868
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of interferon-gamma on complement gene expression in different cell types.
    Lappin DF; Guc D; Hill A; McShane T; Whaley K
    Biochem J; 1992 Jan; 281 ( Pt 2)(Pt 2):437-42. PubMed ID: 1531292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autoantibodies and lymphoproliferative diseases in acquired C1-inhibitor deficiencies.
    Cicardi M; Zingale LC; Pappalardo E; Folcioni A; Agostoni A
    Medicine (Baltimore); 2003 Jul; 82(4):274-81. PubMed ID: 12861105
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elucidation of the substrate specificity of the MASP-2 protease of the lectin complement pathway and identification of the enzyme as a major physiological target of the serpin, C1-inhibitor.
    Kerr FK; Thomas AR; Wijeyewickrema LC; Whisstock JC; Boyd SE; Kaiserman D; Matthews AY; Bird PI; Thielens NM; Rossi V; Pike RN
    Mol Immunol; 2008 Feb; 45(3):670-7. PubMed ID: 17709141
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum concentrations of C reactive protein, alpha1 antitrypsin, and complement (C3, C4, C1 esterase inhibitor) before and during the Vuelta a Espańa.
    Semple SJ; Smith LL; McKune AJ; Hoyos J; Mokgethwa B; San Juan AF; Lucia A; Wadee AA
    Br J Sports Med; 2006 Feb; 40(2):124-7. PubMed ID: 16431998
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Evaluation of C3c, C4 and C1-esterase inhibitor (C1-INH) during unstable angina].
    Danese C; Marcianò F; Ciarla MV; Colotto M; Angrisani L; Ferranti E; Borgia MC
    Minerva Cardioangiol; 2002 Dec; 50(6):667-72. PubMed ID: 12473987
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo decomplementation of guinea pigs with cobra venom factor and anti-C3 serum: analysis of the requirement of C3 and C5 for the mediation of endotoxin-induced death.
    Drake WP; Pokorney DR; Kopyta LP; Mardiney MR
    Biomedicine; 1976 May; 25(3):91-4. PubMed ID: 949521
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Administration of C1-esterase inhibitor during emergency coronary artery bypass surgery in acute ST-elevation myocardial infarction.
    Thielmann M; Marggraf G; Neuhäuser M; Forkel J; Herold U; Kamler M; Massoudy P; Jakob H
    Eur J Cardiothorac Surg; 2006 Aug; 30(2):285-93. PubMed ID: 16829095
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanisms of complement activation and effects of C1-inhibitor on the meconium-induced inflammatory reaction in human cord blood.
    Salvesen B; Nielsen EW; Harboe M; Saugstad OD; Mollnes TE
    Mol Immunol; 2009 Feb; 46(4):688-94. PubMed ID: 18950866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Activation of plasma cascade systems in sepsis: role of C1 inhibitors].
    Zeerleder S; Caliezi C; Redondo M; Devay J; Wuillemin WA
    Schweiz Med Wochenschr; 1999 Oct; 129(39):1410-7. PubMed ID: 10542999
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of supraphysiologic levels of C1-inhibitor on the classical, lectin and alternative pathways of complement.
    Nielsen EW; Waage C; Fure H; Brekke OL; Sfyroera G; Lambris JD; Mollnes TE
    Mol Immunol; 2007 Mar; 44(8):1819-26. PubMed ID: 17101176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.